Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (9513)	4/3/1999 10:46:00 AM
From: Slugger	Read Replies (1) \| Respond to of 17367

From XOMA website: Super Bugs and Super Drugs April 13-14, London, England Pat Scannon, MD, PhD, rBPI-21 Clinical Update Robert/George, Do you think XOMA might announce end of the trial here? What is there to update if trial hasn't ended? Is Scannon going to stand up and say we have now enrolled 390 patients in our study and then sit down? Also, the timing appears to coincide with statements by XOMA (or maybe it was Michael Murphy) two weeks ago that we were very close to the end. Slugger